Annual Retained Earnings
-$978.23 M
-$105.37 M-12.07%
31 December 2023
Summary:
CymaBay Therapeutics annual retained earnings is currently -$978.23 million, with the most recent change of -$105.37 million (-12.07%) on 31 December 2023. During the last 3 years, it has fallen by -$211.37 million (-27.56%).CBAY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$978.23 M
-$41.90 M-4.48%
31 December 2023
Summary:
CymaBay Therapeutics quarterly retained earnings is currently -$978.23 million, with the most recent change of -$41.90 million (-4.48%) on 31 December 2023.CBAY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -27.6% | -27.6% |
| 5 y5 years | -56.3% | -56.3% |
CBAY Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | +196.9% | +180.4% |
CymaBay Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$978.23 M(+12.1%) | -$978.23 M(+4.5%) |
| Sept 2023 | - | -$936.33 M(+3.8%) |
| June 2023 | - | -$902.44 M(+0.1%) |
| Mar 2023 | - | -$901.63 M(+3.3%) |
| Dec 2022 | -$872.86 M(+13.8%) | -$872.86 M(+3.1%) |
| Sept 2022 | - | -$846.22 M(+3.0%) |
| June 2022 | - | -$821.72 M(+3.4%) |
| Mar 2022 | - | -$794.63 M(+3.6%) |
| Dec 2021 | -$766.86 M(+13.3%) | -$766.86 M(+3.6%) |
| Sept 2021 | - | -$740.31 M(+3.2%) |
| June 2021 | - | -$717.63 M(+3.3%) |
| Mar 2021 | - | -$694.41 M(+2.6%) |
| Dec 2020 | -$676.86 M(+8.1%) | -$676.86 M(+2.4%) |
| Sept 2020 | - | -$661.11 M(+1.8%) |
| June 2020 | - | -$649.69 M(+1.7%) |
| Mar 2020 | - | -$638.96 M(+2.1%) |
| Dec 2019 | -$625.87 M(+19.7%) | -$625.87 M(+4.9%) |
| Sept 2019 | - | -$596.46 M(+4.6%) |
| June 2019 | - | -$570.18 M(+4.4%) |
| Mar 2019 | - | -$546.14 M(+4.4%) |
| Dec 2018 | -$523.06 M | -$523.06 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -$503.62 M(+3.8%) |
| June 2018 | - | -$485.05 M(+3.7%) |
| Mar 2018 | - | -$467.52 M(+3.8%) |
| Dec 2017 | -$450.52 M(+6.5%) | -$450.52 M(+1.1%) |
| Sept 2017 | - | -$445.47 M(+1.9%) |
| June 2017 | - | -$437.24 M(+2.1%) |
| Mar 2017 | - | -$428.31 M(+1.3%) |
| Dec 2016 | -$422.96 M(+6.7%) | -$422.96 M(+1.7%) |
| Sept 2016 | - | -$416.01 M(+1.4%) |
| June 2016 | - | -$410.13 M(+1.7%) |
| Mar 2016 | - | -$403.14 M(+1.7%) |
| Dec 2015 | -$396.29 M(+4.1%) | -$396.29 M(+1.5%) |
| Sept 2015 | - | -$390.31 M(+1.5%) |
| June 2015 | - | -$384.44 M(+0.4%) |
| Mar 2015 | - | -$383.09 M(+0.6%) |
| Dec 2014 | -$380.76 M(+9.1%) | -$380.76 M(+3.5%) |
| Sept 2014 | - | -$368.04 M(+1.6%) |
| June 2014 | - | -$362.08 M(+0.9%) |
| Mar 2014 | - | -$358.90 M(+2.9%) |
| Dec 2013 | -$348.84 M(+5.9%) | -$348.84 M |
| Dec 2012 | -$329.48 M | - |
FAQ
- What is CymaBay Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for CymaBay Therapeutics?
What is CymaBay Therapeutics annual retained earnings?
The current annual retained earnings of CBAY is -$978.23 M
What is the all time high annual retained earnings for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual retained earnings is -$329.48 M
What is CymaBay Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CBAY is -$978.23 M
What is the all time high quarterly retained earnings for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly retained earnings is -$348.84 M